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As detailed in the Appreciation piece 
written by Carol Moberg, Ralph’s dis-
covery and investigation of DCs con-
stituted an enormous contribution to 
immunology. However, Ralph’s influence 
extended far beyond the strictly scien-
tific.  Below,  some  of  Ralph’s  closest 
colleagues  and  friends  reflect  on  the 
long-lasting effects of his unwaver-
ing mentorship, enthusiasm, generosity, 
and friendship.
Also  in  this  issue  is  a  Perspective, 
originally  commissioned  by  Ralph  and 
written by Robin Weiss and Peter Vogt. 
Ralph passed away before he could read 
this  engaging  piece,  which  celebrates 
the centennial of the publication in the 
JEM of the Nobel Prize-winning work   
of  Peyton  Rous.  In  addition  to  their   
Nobel  Prizes,  Ralph  and  Peyton  Rous 
shared the distinctions of being long-
time leaders of Rockefeller laboratories 
and editors of this journal.
Michel Nussenzweig
When Zanvil Cohn introduced me to 
Ralph Steinman in 1977, he was working 
at the bench. Ralph continued to work 
during our 45 minute interview, at the 
end of which he told me that my ideas 
were from “outer space,” and that I should 
drop them and come work with him on 
DCs. The next day I did, and it was one 
of the best decisions I ever made.
Those three years working together 
were among the most exciting in my ca­
reer in science. We worked in a small room 
with Ralph’s technician, Maggi Pack. Our 
routine was to spend the entire morning 
collecting  and  processing  spleens,  and 
talking about the experiments. There were 
always so many different possibilities for 
experiments,  but  never  enough  DCs.   
Despite the daily frustrations of difficult 
technical work at the bench, I was thrilled 
to be there and to spend the day talking to 
Ralph. He taught me how to do experi­
ments, how to think about science, and 
how to be a mentor. Later, he also taught 
me how to be an editor of the JEM.
Others  will  comment  on 
Ralph’s tremendous determina­
tion, intelligence, and generos­
ity. For me Ralph was above 
all a great friend and mentor. 
He will be sorely missed.
Carl Nathan
One of my happiest memories 
of Ralph took place in a gilded 
ballroom  at  the  Pierre  Hotel   
on  a  beautiful  September  day   
in 2007 as I watched him re­
ceive  the  Lasker  Award.  His   
demeanor  was  serious  as  Joe 
Goldstein cataloged his contri­
butions to immunology, but he 
lit up with a huge grin when 
Joe described Ralph’s greatest 
interest: dancing with Claudia. 
Besides science, family was the 
driver in Ralph’s life, both his 
wonderful first family –Claudia, 
Adam,  Lesley,  and  Alexis— 
and his “second family” of colleagues, 
co­workers, and trainees.
What was my place in his second 
family? Ralph was my big brother from 
the moment I joined the Rockefeller 
faculty in 1977. The triple bonds of our 
shared progress through Harvard Medi­
cal School, residency at Massachusetts 
General Hospital, and membership in 
the Cohn laboratory led him to ex­
press  life­long loyalty and generosity.   
When I needed guidance, he came into 
my office or invited me into his and 
told me what I needed to hear. When I 
needed  support,  he  gave  it  unstint­
ingly. For example, 20 years ago, 5 years 
after  I  moved  to  Cornell  University 
Medical  College,  National  Institutes   
of  Health  reviewers  announced  that 
they  would  not  renew  funding  for   
the three separate MD­PhD programs 
that the Medical College maintained 
at the time: a Cornell–Cornell program, 
a  Rockefeller–Cornell  program,  and  a 
Sloan­Kettering–Cornell program. The 
reviewers said they would only consider 
funding a unified program. They ended 
the  critique  with  the  prediction  that 
they  didn’t  think  we  could  bring  it   
off. The Cornell administration charged   
me with trying to set this up. It went   
nowhere until Ralph stepped forward 
with  his  full  and  influential  support,   
and the Tri­Institutional MD­PhD Pro­
gram has thrived ever since. I can never 
repay Ralph’s brotherhood, except by 
continuing  to  support  the  goals  we 
shared  with the passion he brought to   
his work.
And Ralph was a man of passions. 
He did not just believe, he believed 
passionately in the potential of DCs,   
in  addition  to  the  need  to  support 
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laboratory. Ralph and his closest friend 
and colleague, Zanvil Cohn, shared all 
the laboratory space on the fourth floor 
of The Detlev Bronk Building. It was 
in  these  laboratories,  which  seemed 
outdated even in 1988 and have not ap­
preciably changed over the last 20 years, 
that  Ralph  and  his  colleagues  made 
such important discoveries. In my first 
meeting with Ralph, he described DCs 
as being “special” based on their strik­
ing potency for activating naive T cells. 
This early finding was the antecedent 
for Ralph’s later work focused on tar­
geting  DCs  directly  with  vaccines  to 
improve T cell immunity. I was fortu­
nate to be intimately involved with this 
work almost 20 years later.
Ralph was unique in his ability to 
have a broad perspective for what was 
scientifically  and  potentially  clinically 
important, yet maintain a profound un­
derstanding of the cellular and molecu­
lar  basis  for  the  underlying  biology. 
Ralph used this broad, yet specific, ex­
pertise and committed himself to trans­
lational  research  in  two  major  ways. 
First, as an editor of the JEM, he was 
instrumental  in  strongly  encouraging 
submission of papers describing experi­
ments  with  human  tissues,  allowing 
those  doing  this  type  of  research  to 
publish  it  in  a  high  quality  journal 
an Assistant Professor in the same de­
partment  in  which  I  had  trained,  I 
knew I needed to establish my inde­
pendence. It was hard to work down 
the hall from Ralph and not get caught 
up in DC mania. DCs were finally be­
ing accepted by the immunology com­
munity.  However,  I  was  determined   
to keep focused on my own research   
program. This  worked  well,  or  so  I 
thought, for a decade. At that time Gwen   
Randolph and I were studying a funny 
subset of monocytes that, after trans­
migrating  endothelium  would  cross 
back from the basal to the apical side. 
We  discussed  these  data  with  Ralph. 
He suggested a few experiments. Sure 
enough, these cells turned out to be 
monocytes that differentiated into im­
mature DCs and were crossing the en­
dothelium from the abluminal to the 
luminal side, the way they would enter 
afferent lymphatic channels in vivo.
The lesson I learned from this is that 
there are two types of immunologists: 
Those who are studying DCs and those 
who don’t realize they are studying DCs!
Bob Seder
My first interaction with Ralph was in 
1988 when I was a second year medical 
resident at New York Hospital/Cornell 
Medical Center doing a rotation in his 
younger  scientists,  the  application  of 
exacting rigor in scientific evaluation, 
the importance of moving beyond in 
vitro and animal models into human 
studies, and the key role in the scien­
tific community of his beloved jour­
nal,  the  JEM.  During  our  30  years 
together on the editorial board, I saw 
no one work harder or do more behind 
the scenes to sustain the journal’s phi­
losophy and effectiveness than Ralph.
If  I  had  to  pick  one  word  to   
summarize  Ralph’s  personality  and 
impact,  it  would  be  “generativity.” 
Generativity  describes  all  three  of 
Ralph’s greatest interests: family, ed­
ucation, and research. It was also his 
subject matter: DCs generate an immune 
response by educating other cells in 
their family. Ralph did what he studied.
Ralph gave a Harvey lecture in Jan­
uary 2010. In one of those decisions for 
which  I  will  never  forgive  myself,   
I  allowed  another  obligation  to  keep   
me from attending. Later, Julien Vau­
bourgeix,  one  of  my  postdoctoral  fel­
lows, told me about the lecture and   
said, “Now I know why I want to be   
a  scientist!”  No  tribute  could  have 
pleased Ralph more, perhaps not even 
a Nobel Prize.
Bill Muller
Ralph  had  an  uncanny  ability  to  cut 
right to the heart of the matter, whether 
it was designing an experiment, summa­
rizing a manuscript, critiquing a grant, or 
describing a movie plot. He could take 
the most complex data and distill the es­
sence  into  one  or  two  concise  simple 
sentences that made one think, “That’s so 
obvious! Why didn’t I think of that?”
Ralph had the most amazing smile. 
It  was  radiant.  It  was  genuine;  he 
looked so relaxed when he was smil­
ing. And he always seemed to be smil­
ing, no matter how life was treating 
him.  The  smile  was  infectious  and 
those  around  him  found  themselves 
smiling, too. Just to be around him 
made me feel better.
When people would ask about my 
relationship with Ralph, I used to say 
that I was his first graduate student, and 
the only one NOT to work on DCs. 
When I came back to Rockefeller as 
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encouragement of submissions by au­
thors able to make a convincing ar­
gument  for  the  significance  of  their 
findings. Above all, Ralph was a person­
able  and  extremely  positive  colleague 
and mentor who encouraged the very 
best  from  all  of  us,  but  in  particular 
from  younger  scientists  struggling  to 
make  their  name  in  the  field.  Ralph 
Steinman left us with many professional 
and life lessons but his last, on how to 
confront death with enormous courage 
and dignity, was to the me the most 
moving and powerful. In the end, the 
Nobel was merely the final triumph   
in the life of a man who was already a   
laureate not only in his outstanding re­
search accomplishments and dedication 
to the translation of science for the bet­
terment  of  humanity  but  also  for  his 
personal integrity. Thanks, Ralph, for 
your  friendship  and  support  and  for 
leaving us with this inspiring legacy!
Anne O’Garra
Ralph Steinman was already very famous 
as the father and discoverer of DCs by 
the time I met him. He was modest, 
and always had a persistent excitement 
with other people’s new findings, espe­
cially  those  related  to  DCs.  I  got  to 
know Ralph, first in the 1990s when 
we co­organized (together with Jacques 
Banchereau) the first of a few Dendritic 
Cell Keystone Conferences, and then 
through the JEM Board, which I joined 
in  2004.  He  was  the  most  effective   
conference  organizer,  thoroughly  re­
viewing each abstract, attending every 
single talk, taking detailed notes, and, 
importantly,  engaging  with  and  en­
couraging  young  researchers.  He  was 
the most diligent reviewer and editor   
I  have  ever  met,  always  concerned 
about publishing new findings and re­
acting  against  overzealous  reviewers, 
who either nit­picked or asked for too 
much.  As  he  used  to  say  “publishing 
manuscripts is an evolving process – we 
cannot have all the answers in the one 
paper, there will always be some un­
answered  questions,  but  science  must 
go forward.” I learned a lot from Ralph 
and will miss him sorely, both as a friend 
and as a mentor.
Ralph was tireless, rigorous, deman­
ding,  courageous,  humble,  and  de­
termined. I speak for so many of his 
colleagues in saying that he was also   
incredibly  loyal.  He  emphasized  our 
strengths and was honest yet respectful 
and supportive of our weaknesses. Al­
though the Nobel Prize is certainly the 
highest scientific honor, and well de­
served  and  appreciated,  the  greatest 
prize for Ralph and his legacy will be 
for the scientific community to dedi­
cate themselves to developing success­
ful  vaccines  to  prevent  HIV,  malaria 
and tuberculosis and help treat cancer. 
His scholarship, mentorship, and friend­
ship will be missed in a way that words 
cannot convey. As such, it is not just 
DCs that were “special.”
Gerold Schuler
Ralph changed my life in many ways. 
My time with him was just wonderful. 
The scientific findings we made and   
the training I received have obviously 
helped me in my career. However, he 
also impressed and influenced me very 
deeply  as  a  caring  and  understanding 
human  being,  especially  because  his 
family was so important to him. I con­
sider myself lucky that Ralph was my 
teacher, mentor, and friend. I miss him 
and  hope  to  see  him  again  in  other 
spheres. Ralph, thank you for all you 
gave me.
Alan Sher
Ralph  Steinman  leaves  a  legacy  that   
extends  beyond  his  groundbreaking 
discovery of DCs and the numerous 
seminal  contributions  to  immunology 
of  his  group  at  Rockefeller.  To  the 
many  of  us  who  were  fortunate  to 
have interacted closely with Ralph, he 
served as a model of scientific leader­
ship to which we all might aspire. His 
dedication to the field of immunology   
extended beyond advocating for DCs 
and vaccines, his own areas of research 
interest. He was also vocal in his oppo­
sition  to  trends  in  the  field  that  he   
believed to be misdirected or unfruit­
ful. As a senior editor of the JEM, he 
was  uncompromisingly  rigorous  but   
at the same time notably generous in his 
read by so many basic immunologists. 
Second,  Ralph  devoted  much  of  his 
own efforts to what he called “Vaccine 
Science” to develop vaccines for infec­
tions including HIV, malaria, and tuber­
culosis, where T cells play a critical role.
Ralph  directly  trained  or  played  a 
major role in the development and suc­
cess of a very large number of accom­
plished,  first­rate  investigators  around 
the world. As a board member of Key­
stone he promoted the idea for the short 
talks by young investigators at plenary 
sessions. Over the past few years, he 
spent a substantial amount of time estab­
lishing  The  International  Society  for 
Dendritic  Cell  and  Vaccine  Science,   
“a web­based society to promote col­
laboration  of  dendritic  cell  biologists 
and vaccine scientists.” A highlight of 
Ralph’s vision of integrating the biology 
of  DCs  and  Vaccine  Science  was 
DC2010:  Forum  on Vaccine  Science. 
Antonio Lanzavecchia, Federica Sallusto, 
Markus Manz, and Giorgio Noseda or­
ganized this meeting, which took place 
September 26–30 in Lugano, Switzer­
land almost exactly one year prior to his 
passing.  It  was  a  wonderful  scientific 
program  with  outstanding  basic  and 
clinical talks on the role of DCs. Ralph 
was the closing speaker, as was fitting.
Over the past several years, Ralph 
remained very private and rarely talked 
about his illness. I would ask periodi­
cally about how he was doing, purely 
out of courtesy, and he would then de­
scribe things in precise detail and some­
times wonderment about how some   
of the treatments were going, especially 
the potency of anti–CTLA­4. How­
ever the majority of our conversations   
focused on data, his family, and an oblig­
atory and uninterrupted 10 minutes on 
the perils of research funding. Having 
known Ralph for over 20 years, I was 
fortunate to get to know his wife Claudia 
and daughter Alexis very well. They 
are warm, engaging, outgoing, and un­
derstanding  of  the  constant  intrusions 
by so many of us into Ralph’s time. 
Ralph was always in a good mood when 
he  was  with  his  family,  which  also   
includes  Adam  and  Leslie,  their  re­
spective spouses, and of course his pre­
cious grandchildren.2346 Remembering Ralph Steinman | Banchereau et al.
Jacques Banchereau
I met Ralph nearly 20 years ago. At the 
time,  our  laboratories  had  concluded 
that GM­CSF was critical for the gen­
eration of DCs in vitro, both in mice 
and  humans.  This  was  the  beginning   
of a long friendship and collaboration 
centered on his original discovery that 
those DCs were an essential element of 
the immune system. DC meetings were 
launched, starting in Annecy, France, in 
1994. At last, the scientific community 
had realized that these “dendritic cells” 
were  not  just  funny  macrophages! 
Ralph and I did not miss a DC meet­
ing for the next 16 years.
Ralph was a true friend and the most 
insightful and generous collaborator, as 
he never refrained from being sincere. 
My decision to leave industry (Schering­ 
Plough/DNAX) and join the Ameri­
can  academic  system  to  build  the   
Baylor  Institute  for  Immunology  Re­
search in Dallas did not enthuse Ralph, 
as  he  was  worried  about  the  funding   
of human studies. Yet, this gave us the   
opportunity  to  work  together  on  a   
program  project  aimed  at  using  DCs   
to  induce  tumor­specific  immune  re­
sponses in cancer patients. This project 
eventually got funded and allowed us   
to demonstrate the therapeutic value of 
DCs generated by culturing monocytes 
with GM­CSF and interferon­. Even­
tually Ralph used these very cells for his 
own therapy! I will never forget those 
long  grant  writing  days  with  Ralph, 
Karolina  Palucka,  Joseph  Fay,  and   
Madhav Dhodapkar. What a privilege 
to be able to discuss DCs with Ralph 
and, during the breaks, learn from him 
how to dance salsa!
Though Ralph spent most of his life 
designing and performing the most ele­
gant mouse studies, he was the strongest 
supporter  of  human  immunology  and 
was highly engaged in the field in many 
ways. After all, with Madhav Dhodapkar 
and Nina Bhardwaj, he was among the 
first to inject human DCs into volun­
teers and to demonstrate their immuno­
genicity  in  humans.  In  recent  years, 
Ralph spent countless hours promoting 
this  field.  As  an  advisor  to  the  Dana 
Foundation, he established grants to sup­
port  investigators  dedicated  to  human 
immunology studies. He led the Dana 
Foundation  to  establish  an  Award  in 
Human Immunology Research given in 
collaboration with the American Associ­
ation  for  Immunologists  (AAI)  every 
year at the AAI annual meeting. I have 
been a privileged recipient of this pre­
cious prize. Ralph also spent consider­
able time with the National Cancer 
Institute to encourage the development 
of cancer immunotherapy with an em­
phasis on cancer vaccines, of which he 
was an ardent advocate. He was impa­
tient to see faster progress and increased 
funding for this field. As if to compen­
sate, he slept short nights, ran in the early 
mornings,  and  kept  an  amazing  pace 
during his long working hours. And he 
never  hesitated  to  take  time  from  his 
busy  schedule  to  help  his  friends.  He 
traveled south to Texas countless times 
to support the Baylor Institute for Im­
munology Research, as well as the MD 
Anderson  Immunology  program  in 
Houston. There,  he  encouraged  us  to 
move  forward  with  our  studies  on   
human lupus and cancer and with the 
development of HIV clinical trials. We 
owe it to this remarkable scientist and 
friend to “keep up the good work,” as 
he used to tell us, always with a smile.
Kayo Inaba
I first met Ralph at the Naito Foun­
dation  International  Symposium  on 
Self­Defense  Mechanisms,  Role  of 
Macrophages, held in Tokyo Novem­
ber 2–4, 1981. That was Ralph’s first 
visit to Japan. I had started my research 
into DCs and macrophages in 1978 at 
Kyoto  University,  following  Ralph’s 
discovery of dendritic cells with Prof. 
Zanvil A. Cohn in 1973. At that time, 
no one believed that DCs could be a 
unique cell type that could initiate and 
regulate immune responses. I joined 
Ralph’s laboratory in 1982, and stayed 
for  26  months.  After  I  returned  to 
Kyoto,  we  continued  to  collaborate 
professionally  in  our  research.  On  a 
personal  level,  our  respective  families 
kept in close contact. I am privileged   
to  have  such  long­standing  relations 
throughout all these years.
Ralph’s  amazing  mind  has  always 
commanded  my  greatest  admiration 
and  respect.  During  his  extraordinary 
career, he trained many excellent students 
and post­docs from many countries,   
including  Asian  countries  such  as 
China, Korea, and Japan. He was al­
ways encouraging and enthusiastic and 
excited  about  findings,  even  those  of 
others.  Every  time  we  met  him,  he 
asked “What’s new today?”
Ralph passed away after a four and a 
half year battle with pancreatic cancer. 
Ralph  was  passionately  involved  in 
science until the last days of his life. The 
news of Ralph’s passing left me with   
a  profound  sense  of  grief,  not  only   
because  I  believe  he  himself  deeply 
regretted  the  “loss”  of  his  own  life   
but  also  because  Ralph’s  passing  will   
be a great loss to the field of immu­
nology. I sincerely pray for him to rest   
in peace.
Fern Cohn
I remember the day very clearly. Zan 
came  home  from  the  laboratory  and   
announced, “Ralph made a very im­
portant observation today.” Then fol­
lowed the details. Ralph had come to 
Zan’s office to ask him to look into   
his microscope. Zan went to Ralph’s 
laboratory,  looked  through  Ralph’s   
microscope, and saw what Ralph had 
just seen.
It was their very first view of what 
they were later to call the dendritic cell.